-The Hindu Beniwal’s claim of exclusive right to appoint Lokayukta is not in keeping with spirit of Constitution: Bench The Supreme Court has reiterated that the Governor is bound to act on the aid and advice of the Council of Ministers, unless he acts as persona designata i.e., eo nomine under a particular statute or acts in his own discretion under the exceptions provided for in the Constitution itself. Upholding the appointment of...

-The Times of India NEW DELHI: The EPFO (Employees' Provident Fund Organization), which manages lifetime savings of 6.15 crore individuals, has just made life tougher for workers. Employees will now have to prove that their employers deducted the statutory dues while giving them salaries, a move that will further benefit construction companies and contractors in particular who often claim that they have paid salaries to thousands of workers without actually transferring...

-The Times of India The next time you apologize for your home looking like a dump, spare a thought for Shobhraj Kumar. Most people who hurry past the garbage dump at Masjid Moth would find it difficult to stand there for a few minutes because of the all-pervading stench. But for Shobhraj and his family of six, the dump is home. The 62-year-old says he has been living in the 20 sq...

-The Hindu The government has approved a Rs. 4,038 crore programme to tackle the Japanese encephalitis and acute encephalitis syndrome in 60 priority districts With thousands of young lives being lost and an equal number of children rendered disabled for life, the government has prepared a comprehensive strategy to tackle Japanese encephalitis (JE) and acute encephalitis syndrome (AES). The dreaded disease has already spread to 17 States affecting 171 districts. With the Cabinet...

-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...